Complicated Intra Abdominal Infection clinical trials

Explore recruiting complicated intra abdominal infection clinical trials.

Recruiting complicated intra abdominal infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Complicated Intra Abdominal Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multi-Center, Randomized, Single-Blind Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complicated Urinary Tract Infection, Acute Uncomplicated Pyelonephritis, Hospital-Acquired Bacterial Pneumonia, Ventilator-Associated Bacterial Pneumonia, and Complicated Intra-Abdominal Infection due to Carbapenem Resistant Enterobacterales (OP0595-6)

France, Czechia, Greece, Slovakia, Latvia, Croatia +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

C3601008 - A PHASE 2A MULTICENTER, OBSERVER-BLINDED, RANDOMIZED 2 ARM STUDY TO INVESTIGATE PHARMACOKINETICS, SAFETY, TOLERABILITY AND EFFICACY OF INTRAVENOUS AZTREONAM-AVIBACTAM ± METRONIDAZOLE COMPARED TO BEST AVAILABLE THERAPY (BAT) IN PEDIATRIC PARTICIPANTS 9 MONTHS TO LESS THAN 18 YEARS OF AGE WITH SERIOUS GRAM-NEGATIVE BACTERIAL INFECTIONS INCLUDING COMPLICATED INTRA-ABDOMINAL INFECTION

Hungary, Spain, Greece, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

C3601010: A Phase 2A, 2-Part, Open-Label, Non-Randomized, Multicenter, Single and Multiple Dose Trial to Evaluate Pharmacokinetics, Safety and Tolerability of Aztreonam and Avibactam ± Metronidazole in Neonates and Infants From Birth to Less Than 9 Months of Age With Suspected or Confirmed Infections Due to Gram-Negative Pathogens Requiring Intravenous Antibiotic Treatment

Slovakia, Greece, Bulgaria, Italy, Hungary, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Complicated Intra Abdominal Infection trials by city

Complicated Intra Abdominal Infection in Toronto Complicated Intra Abdominal Infection in Vancouver Complicated Intra Abdominal Infection in Montreal Complicated Intra Abdominal Infection in Calgary Complicated Intra Abdominal Infection in Edmonton Complicated Intra Abdominal Infection in Ottawa Complicated Intra Abdominal Infection in Winnipeg Complicated Intra Abdominal Infection in Quebec City Complicated Intra Abdominal Infection in Hamilton Complicated Intra Abdominal Infection in Kitchener Complicated Intra Abdominal Infection in London Complicated Intra Abdominal Infection in Halifax Complicated Intra Abdominal Infection in New York Complicated Intra Abdominal Infection in Los Angeles Complicated Intra Abdominal Infection in Chicago Complicated Intra Abdominal Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease